Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.
Pawlak D, Rangger C, Kolenc Peitl P, Garnuszek P, Maurin M, Ihli L, Kroselj M, Maina T, Maecke H, Erba P, Kremser L, Hubalewska-Dydejczyk A, Mikołajczak R, Decristoforo C. Pawlak D, et al. Among authors: decristoforo c. Eur J Pharm Sci. 2016 Mar 31;85:1-9. doi: 10.1016/j.ejps.2016.01.023. Epub 2016 Jan 27. Eur J Pharm Sci. 2016. PMID: 26826279 Free PMC article.
99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.
Gabriel M, Decristoforo C, Maina T, Nock B, vonGuggenberg E, Cordopatis P, Moncayo R. Gabriel M, et al. Among authors: decristoforo c. Cancer Biother Radiopharm. 2004 Feb;19(1):73-9. doi: 10.1089/108497804773391702. Cancer Biother Radiopharm. 2004. PMID: 15068614 Clinical Trial.
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
Elsinga P, Todde S, Penuelas I, Meyer G, Farstad B, Faivre-Chauvet A, Mikolajczak R, Westera G, Gmeiner-Stopar T, Decristoforo C; Radiopharmacy Committee of the EANM. Elsinga P, et al. Among authors: decristoforo c. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1049-62. doi: 10.1007/s00259-010-1407-3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20306035 Free PMC article.
[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.
Knetsch PA, Petrik M, Griessinger CM, Rangger C, Fani M, Kesenheimer C, von Guggenberg E, Pichler BJ, Virgolini I, Decristoforo C, Haubner R. Knetsch PA, et al. Among authors: decristoforo c. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1303-12. doi: 10.1007/s00259-011-1778-0. Epub 2011 Apr 13. Eur J Nucl Med Mol Imaging. 2011. PMID: 21487838
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
Ocak M, Helbok A, Rangger C, Peitl PK, Nock BA, Morelli G, Eek A, Sosabowski JK, Breeman WA, Reubi JC, Decristoforo C. Ocak M, et al. Among authors: decristoforo c. Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1426-35. doi: 10.1007/s00259-011-1818-9. Epub 2011 Apr 29. Eur J Nucl Med Mol Imaging. 2011. PMID: 21528387 Free article.
Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.
Helbok A, Rangger C, von Guggenberg E, Saba-Lepek M, Radolf T, Thurner G, Andreae F, Prassl R, Decristoforo C. Helbok A, et al. Among authors: decristoforo c. Nanomedicine. 2012 Jan;8(1):112-8. doi: 10.1016/j.nano.2011.04.012. Epub 2011 May 20. Nanomedicine. 2012. PMID: 21645641
195 results